All News
|
News Release
Los Institutos Nacionales de Salud (NIH, por sus siglas en inglés) anunciaron hoy una subvención de $12 millones para proyectos de promoción de salud y participación comunitaria en regiones con minorías étnicas y raciales afectadas de manera desproporcionada por la pandemia de COVID-19. Con estos fondos, RTI International, una institución de...
Showing 10 out of 1750 results
|
Research Feature
Months ago, when news came flooding in about the dire toll the novel coronavirus can take on the body, so did the phone calls to Beth Kozel, M.D., Ph.D. A clinical geneticist in the Division of Intramural Research (DIR) at the National Heart, Lung, and Blood Institute (NHLBI), Kozel cares for adult and pediatric patients with rare connective tissue...
|
News Release
Los Institutos Nacionales de Salud (NIH, por sus siglas en inglés) anunciaron hoy una subvención de $12 millones para proyectos de promoción de salud y participación comunitaria en regiones con minorías étnicas y raciales afectadas de manera desproporcionada por la pandemia de COVID-19. Con estos fondos, RTI International, una institución de...
|
News Release
The National Institutes of Health today announced a $12 million award for outreach and engagement efforts in ethnic and racial minority communities disproportionately affected by the COVID-19 pandemic. The award to RTI International, a non-profit research institution, will support teams in 11 states established as part of the NIH Community...
|
News Release
The National Institutes of Health has launched two of three adaptive Phase 3 clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19. Part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, these trials will be conducted at more than 100...
|
News Release
The trend could threaten decades of public health work against heart disease After nearly 15 years on an upward trend, awareness among Americans about high blood pressure and how to control and treat it is now on the decline, according to a new study. Even with the help of blood pressure medications, some groups, including older adults, are less...
|
Research Feature
Researchers supported by the National Institutes of Health have launched a key study to explore the safety and effectiveness of convalescent plasma in treating patients who have recently (within the last week) developed mild to moderate symptoms of COVID-19 disease. The study, which focuses on patients not yet hospitalized, comes on the heels of an...
|
Research Feature
The coronavirus pandemic has caused tragedy and turmoil for millions of people around the world, but it has been particularly unkind to one group whose health journey is often overlooked: Those with sickle cell disease. A growing number of studies now suggest that people with this painful genetic blood disorder who also are infected with SARS-CoV-2...
|
Research Feature
As the coronavirus pandemic continues to disrupt daily living, researchers are taking a closer look at one requirement for health that many people take for granted: sleep. And they’ve concluded, perhaps not surprisingly, that improving our sleep schedule and quality is an important part of coping with these stressful times and defending against...
|
NHLBI in the Press
In a step toward personalized medicine, researchers are reporting that the use of genetic testing to guide selection of blood thinner medication led to a 34% decrease in the number of patients who had serious adverse events following balloon angioplasty, a common treatment for heart disease.
|
NHLBI in the Press
After nearly a decade of decline, the death rate from lung clots is now on the rise, particularly among African Americans and people under the age of 65, researchers are reporting.